Arrhythmias in the pregnant patient: current concepts in evaluation and management.
Maternal arrhythmias during pregnancy may jeopardize the health of both mother and fetus. The correct identification of the arrhythmia is critical in the pregnant patient. Treatment should be reserved for arrhythmias that are hemodynamically unstable or cause debilitating symptoms. When medications are deemed necessary, the physician should use as few drugs as possible at the lowest effective doses and choose drugs with a history of safe use in pregnancy. Resuscitation of a pregnant patient in cardiac arrest should be modified with regard to the normal physiologic changes of pregnancy. With careful management, most of these challenging patients will have excellent outcomes.
Division of Cardiovascular Medicine, Department of Medicine, University of Florida College of Medicine, Box 100277, Gainesville, FL 32610-0277, USA.
Jordana
J
Kron
Jamie B
JB
Conti
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D001145:Arrhythmias, Cardiac / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D017147:Defibrillators, Implantable / Q000592:standards; D015716:Electrocardiography, Ambulatory / Q000592:standards; D005260:Female; D005323:Fetal Monitoring; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000145:classification / Q000175:diagnosis / Q000628:therapy
D000889:Anti-Arrhythmia Agents